Comparison of efficacy and safety of oral agents for the treatment of relapsing–remitting multiple sclerosis

Por Guarnera C, Bramanti P, Mazzon E
Publicado em 2017-07-01

Effects of zileuton and montelukast in mouse experimental spinal cord injury

Por Genovese, T, Rossi, A, Mazzon, E, Di Paola, R, Muià, C, Caminiti, R, Bramanti, P, Sautebin, L, Cuzzocrea, S
Publicado em 2007

The 5-lipoxygenase inhibitor, zileuton, suppresses prostaglandin biosynthesis by inhibition of arachidonic acid release in macrophages

Por Rossi, A, Pergola, C, Koeberle, A, Hoffmann, M, Dehm, F, Bramanti, P, Cuzzocrea, S, Werz, O, Sautebin, L
Publicado em 2010

Inhibition of NF-κB activation sensitizes U937 cells to 3′-azido-3′-deoxythymidine induced apoptosis

Por Matteucci, C, Minutolo, A, Balestrieri, E, Marino-Merlo, F, Bramanti, P, Garaci, E, Macchi, B, Mastino, A
Publicado em 2010

Effect of tumour necrosis factor-α receptor 1 genetic deletion on carrageenan-induced acute inflammation: a comparison with etanercept

Por Mazzon, E, Esposito, E, Di Paola, R, Muià, C, Crisafulli, C, Genovese, T, Caminiti, R, Meli, R, Bramanti, P, Cuzzocrea, S
Publicado em 2008